The Cancer Treatment Revolution
Since the mid-1950s, when he witnessed some of the first patient experiments using combination chemotherapy, David G. Nathan, MD, has played a pivotal role in the dramatic history of cancer care and research.
Now, Nathan — an acclaimed pediatric hematologist who served as Dana-Farber's president from 1995 to 2000 and has long been affiliated with Children's Hospital Boston — recounts that history's triumphs and struggles in a book called The Cancer Treatment Revolution: How Smart Drugs and Other New Therapies Are Renewing Our Hope and Changing the Face of Medicine.
Published in March by John Wiley & Sons, the work recounts the stories of three patients with invasive cancers treated at Dana-Farber and its partners in care: Mario, a 19-month-old boy diagnosed with leukemia; Joan, a 62-year-old woman facing metastatic breast cancer; and Ken, a 48-year-old who endured multiple clinical trials for gastrointestinal stromal tumor before his death in 2005. The pages are peppered with the insights of current and former Dana-Farber physicians, researchers, and other staff members.
Buy this book and read its reviews